We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With ST Segment Elevation Myocardial Infarction (STEMI)

This study has been withdrawn prior to enrollment.
(Corporate business decision, may consider different subject population)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01770613
First Posted: January 18, 2013
Last Update Posted: April 27, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
CardioCell LLC
Information provided by (Responsible Party):
Stemedica Cell Technologies, Inc.
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: May 2017
  Estimated Primary Completion Date: May 2016 (Final data collection date for primary outcome measure)